Skandinaviska Enskilda Banken (SEB)
ALT icon

Skandinaviska Enskilda Banken (SEB)’s Altimmune ALT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-62,002
Closed -$454K – 838
2024
Q4 		$454K Hold
62,002
– – ﹤0.01% 722
2024
Q3 		$381K Hold
62,002
– – ﹤0.01% 726
2024
Q2 		$412K Hold
62,002
– – ﹤0.01% 695
2024
Q1 		$631K Hold
62,002
– – ﹤0.01% 694
2023
Q4 		$698K Buy
+62,002
New +$259K ﹤0.01% 737
2023
Q1 		– Sell
-38,559
Closed -$634K – 898
2022
Q4 		$634K Sell
38,559
-2,234
-5% -$25.1K ﹤0.01% 713
2022
Q3 		$520K Buy
+40,793
New +$602K ﹤0.01% 752

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ALT Position: Q1 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Altimmune (ALT) in Q1 2025, closing a stake of 62,002 shares — an estimated $454K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ALT in Q3 2022 and held it in 7 quarters. The position peaked at $698K in Q4 2023. 176 funds tracked by Wall St. Rank hold ALT as of Q1 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Altimmune position as of Q1 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 62,002 Altimmune shares in Q1 2025, an estimated $454K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Altimmune in Q3 2022 and held it in 7 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Altimmune position peaked at $698K in Q4 2023.
  • 176 funds tracked by Wall St. Rank held Altimmune as of Q1 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2025, filed 7 May 2025.